1-2 of 2
Mona Mashayekhi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

Mark S. Diamond, Michelle Kinder, Hirokazu Matsushita, Mona Mashayekhi, Gavin P. Dunn, Jessica M. Archambault, Hsiaoju Lee, Cora D. Arthur, J. Michael White, Ulrich Kalinke, Kenneth M. Murphy, Robert D. Schreiber
Journal: Journal of Experimental Medicine
J Exp Med (2011) 208 (10): 1989–2003.
https://doi.org/10.1084/jem.20101158
Published: 19 September 2011
View article titled, Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Open the PDF for Type I interferon is selectively required by dendritic cells for immune rejection of tumors in another window
Includes: Supplementary data
Journal Articles

Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression

Jörn C. Albring, Michelle M. Sandau, Aaron S. Rapaport, Brian T. Edelson, Ansuman Satpathy, Mona Mashayekhi, Stephanie K. Lathrop, Chyi-Song Hsieh, Matthias Stelljes, Marco Colonna, Theresa L. Murphy, Kenneth M. Murphy
Journal: Journal of Experimental Medicine
J Exp Med (2010) 207 (12): 2551–2559.
https://doi.org/10.1084/jem.20102017
Published: 15 November 2010
View article titled, Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression
Open the PDF for Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression in another window
Includes: Supplementary data